BIVI insider trading
NasdaqCM HealthcareBIOVIE INC.: insider trade history from SEC Form 4 filings.
About BIOVIE INC.
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Company website: bioviepharma.com
BIVI insider activity at a glance
FilingIQ tracks 78 insider transactions for BIVI in filings since Oct 14, 2020. The most recent transaction is dated Aug 28, 2026.
Across the full history, 19 open-market purchases
and 8 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest BIVI Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for BIVI?
- FilingIQ tracks 78 Form 4 insider transactions for BIVI (BIOVIE INC.), covering filings from Oct 14, 2020 onwards. 4 of those are dated within the last 90 days.
- Are BIVI insiders net buyers or net sellers?
- Across the full Form 4 history for BIVI, 19 transactions (24%) were open-market purchases and 8 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BIVI insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is BIVI in?
- BIOVIE INC. (BIVI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $10.26M.
Methodology & sources
Every BIVI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.